As the prospect of import tariffs and drug price reform marshals billions of biopharma investment dollars into the U.S., the ...

Pfizer's Conor Riordan explains how the pharmaceutical giant uses Celonis across 200+ markets to drive toward 95% order ...

Pharmacovigilance is increasingly adopted across pharmaceutical companies, regulatory bodies, clinical research organizations ...

Hold 30- to 60-minute one-on-ones every other week or monthly. Start with the largest late-stage deals; spot-check a handful of the rest to keep the pipeline honest. Inspect each priority opportunity ...

Current therapies such as biological DMARDs showed promising results in treating rheumatoid arthritis patients, and market penetration is expected to be more in the future and expected to drive market ...

The latest update is out from Mayne Pharma Group ( (AU:MYX) ).

(Reuters) -AbbVie raised its 2025 profit forecast on Friday, after strong sales of newer immunology drugs Skyrizi and Rinvoq ...

The coming flu season is the clearest indication yet that biopharma’s long-standing assumptions about predictability, ...

Oct 23 (Reuters) - Medical equipment maker West Pharmaceutical (WST.N), opens new tab raised its annual profit forecast on Thursday, after posting better-than-expected results for the third quarter, ...

J&J lifts full-year sales guidance to as much as $93.9 billion, topping Wall Street forecasts. Orthopedics unit DePuy Synthes to be spun off within 24 months. Strong oncology and immunology sales ...